No savings at 50? I’d buy these 2 FTSE 100 dividend shares to beat the State Pension

I think these two FTSE 100 (INDEXFTSE:UKX) income shares could improve your retirement prospects.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The State Pension is unlikely to be sufficient for most retirees to enjoy financial freedom in older age. It amounts to just £8,767 per annum, which is less than a third of the average UK salary.

As such, buying dividend shares could be a sound idea. They may be able to produce an inflation-beating passive income over the long run that reduces your reliance on the State Pension.

Since the FTSE 100 currently has a 4%+ dividend yield, now could be the right time to buy large-cap shares. With that in mind, here are two FTSE 100 dividend stocks that could improve your long-term income investing future.

National Grid

The threat of the utility sector being nationalised under a Labour government has now receded. This could cause investors to re-evaluate the merits of investing in companies such as National Grid (LSE: NG), which has a long history of delivering consistent dividend growth.

Although the prospects for the UK economy may improve as the Brexit process moves ahead, there continues to be uncertainty across the world economy. For example, tariffs on imported goods have been raised in recent years. They could cause global GDP growth to come under pressure, which may mean that investors adopt an increasingly cautious stance in the coming months.

National Grid’s robust business model that is relatively defensive may therefore become more popular with investors. Its dividend yield of 5.1% is relatively high, and could indicate that it offers a margin of safety. Therefore, alongside its potential to offer a reliable dividend that may increase at a faster pace than inflation, the income return prospects of the stock could mean that now is the right time to buy a slice of it.

RSA

The recent third-quarter update from insurer RSA (LSE: RSA) highlighted an improvement in its underwriting performance compared to previous quarters. This contributed to growth in its operating profit in the first nine months of the year, with the business being on track to deliver full-year results that are in line with its expectations.

RSA is seeking to improve its customer proposition, while growing its business where underwriting conditions allow. This is expected to catalyse its bottom-line growth over the next couple of years, with earnings growth of around 16% expected in the next financial year. Alongside a modest rating, this produces an attractive price-to-earnings growth (PEG) ratio of 0.9.

In terms of the company’s income investing appeal, it currently yields 4%. Its shareholder payouts are covered 1.7 times by net profit, while a rapid growth rate in profitability could lead to a large increase in dividends in the coming years. As such, with dividend investing potential and a valuation that suggests it offers growth at a reasonable price, there could be an appealing opportunity to buy the stock today for the long term.

Peter Stephens has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »